The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.
None
None
Children who present to Rossignol Medical Center for standard care related to neurodevelopmental disorders.
Case-control
Prospective
Not listed
10
Trial groupsSee each trial group below.
Number of Patients with Specific Medical abnormalities
It is unknown if a specific set of biological abnormalities contribute to the formation of many types of neurodevelopmental disorders. The study is intended to identify the relationship between biological abnormalities and neurodevelopmental disorders. The chart will be reviewed for medical diagnoses other than the primary neurodevelopmental disorders.
The number of children with abnormal clinical lab
It is unknown if a abnormalities in specific clinical laboratories are associated with specific neurodevelopmental disorders. The study is intended to identify the relationship between biological abnormalities and neurodevelopmental disorders. The medical chart will be reviewed to determine the number of children with a specific medical disorder who have abnormalities in specific clinical labs.
The number of children who respond to specific treatments
Various behavioral and medical treatments are used for many types of neurodevelopmental disorders but the effectiveness for many of these treatments is not known. The study is intended to identify the relationship between biological abnormalities (and their treatments) and neurodevelopmental disorders. The medical chart will be review to determine the treatments applied to each participant and the participants response.
Click on the lead sponsor to view all of their trials.
Richard Frye
Lead sponsor
Rossignol Medical Center
Sponsor institution
Autism Discovery and Treatment Foundation
Collaborator
